Medical News

RSS

SERCA2a gene therapy proves effective in people with advanced heart failure: Researchers

Researchers at Mount Sinai School of Medicine have developed a new gene therapy that is safe and effective in reversing advanced heart failure. SERCA2a (produced as MYDICAR-) is a gene therapy designed to stimulate production of an enzyme that enables the failing heart to pump more effectively.

4 Jun 2010

Government health IT advisers examine privacy policies

One of the latest hurdles government advisers helping to shape health information technology policy must jump is addressing the amount of control patients should have over their own records, Modern Healthcare reports.

4 Jun 2010

PregLem reports positive Phase III data from PEARL I study of Esmya for uterine fibroids

PregLem, the European specialty biopharmaceutical company focused on women's reproductive medicine, announces positive Phase III data from its second pivotal study (PEARL I) for its lead product Esmya (ulipristal acetate), as an effective treatment for uterine fibroids (myoma) - a condition that affects millions of women worldwide.

4 Jun 2010

Millipore shareholders approve acquisition of all outstanding shares of common stock by Merck KGaA

Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that its shareholders voted at a Special Meeting of Shareholders to approve the previously-announced acquisition of all outstanding shares of common stock of Millipore by Merck KGaA of Germany, the global pharmaceutical and chemical company.

4 Jun 2010

Intellect Neurosciences receives USPTO Notice of Allowance for IN-N01 monoclonal antibody patent

Intellect Neurosciences, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent related to the Company's humanized monoclonal antibody, IN-N01, being developed as a disease-modifying treatment for Alzheimer's disease and other related indications.

4 Jun 2010

International development forum addresses U.S. foreign aid reform

USAID Administrator Rajiv Shah and Rep. Gerald Connolly (D-Va.) discussed the need for a new foreign aid strategy and vision at an international development forum, hosted by InterAction on Wednesday, Congressional Quarterly reports.

4 Jun 2010

Study: Delays in seeking health care appear to be common for Latino women

Delays in seeking health care appear to be common for Latino women in upstate New York, a new study finds. In the latest issue of the journal Ethnicity & Disease, about 70 percent of a group of mostly Caribbean Latinas in the Albany area reported they put off getting health care. Insurance did not seem to be an issue, since 80 percent had insurance, yet 60 percent of the women said that they had a prior chronic medical condition.

4 Jun 2010

Nutrient found in maternal diet provide lasting cognitive, emotional benefits to people with Down syndrome: Study

A nutrient found in egg yolks, liver and cauliflower taken by mothers during pregnancy and nursing may offer lifelong "dramatic" health benefits to people with Down syndrome.

4 Jun 2010

European countries focus on drug price cuts

"European governments grappling to reduce large budget deficits are focusing their cost-cutting on a large spending item — pharmaceuticals," The Wall Street Journal reports. "Several countries in recent weeks, including Spain, Germany and Italy, have proposed or enacted reductions in what they will pay or taken other cost-control measures for various drugs.

4 Jun 2010

FDA approves Perrigo's ANDA for OTC Miconazole Nitrate Vaginal Cream and Suppository

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Miconazole Nitrate Vaginal Cream and Suppository, a generic to Monistat® -1 Combination Pack. Perrigo expects to begin shipping immediately.

4 Jun 2010

Mass. insurers ask for double-digit rate hikes, again

Massachusetts' two largest insurers have again asked regulators for permission to increase their rates. "Blue Cross Blue Shield of Massachusetts, the state's biggest health insurer, is requesting increases averaging 12 percent, on the lower end of the range it submitted earlier in the spring. Harvard Pilgrim Health Care, the number two carrier, wants increases that range from 8.8 percent to 11.9 percent, about the same range it sought in the round that was rejected" (Weisman, 6/3).

4 Jun 2010

New pricing of $19,500 set for Illumina's individual genome sequencing service

Illumina, Inc. today announced a new price of $19,500 for its individual genome sequencing service. In addition, the company announced a price of $14,500 per genome for groups of five or more participants using the same physician. Individuals with serious medical conditions for whom whole-genome sequencing could provide potential direct clinical value will be eligible for special pricing of $9,500 per genome.

From Illumina, Inc. 4 Jun 2010

GHP selects MirixaPro web-based clinical platform to support delivery of MTM services

The Geisinger Health Plan, a regional provider of health benefits to almost 250,000 members in Pennsylvania, has selected Mirixa Corporation's MirixaPro web-based clinical platform to support the delivery of medication therapy management services to its Medicare Part D members.

4 Jun 2010

Health overhaul politics churn as regulators move forward

Los Angeles Times: "Congress is shattering its longstanding reputation for being a gridlocked, lethargic, 'do-nothing' institution, instead compiling a record of landmark policy changes in healthcare, financial industry regulation, economic policy and more. But at the same time, Congress is suffering sky-high levels of public disapproval, signaling a big problem for Democrats as they head into the closing months of the midterm election campaign" (Hook, 6/2).

4 Jun 2010

Drug makers push for more time to pay half-off discount on drugs

Drug makers want 60 days instead of 15 to pay a half-off discount for branded drugs in a Medicare Part D coverage gap, Inside Health Policy reports. The Centers for Medicare and Medicaid Services also intends to ask drug makers to pay disputed amounts ahead of a decision about whether the company must pay the discount.

4 Jun 2010

Anulex Technologies completes $20M Series E financing round

Anulex Technologies, Inc., a privately held medical device manufacturer focusing on soft tissue Preservation & Anular Repair products, announced the first closing of its fifth round of private equity financing which will total a minimum of $20 million. The Series E round was led by a new unnamed strategic investor with participation from existing investors Affinity Capital, Delphi Ventures, MB Venture Partners, New Enterprise Associates, SightLine Partners and Split Rock Partners.

4 Jun 2010

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Given promptly, the antiviral drug oseltamivir (Tamiflu) appears safe and effective for infants hospitalized with influenza, reports a study in the June issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

4 Jun 2010

Early detection and removal of pancreatic cysts may lower cancer risk: Researchers

Working with researchers from the University of Michigan and Indiana University, Van Andel Research Institute investigators have developed a method that could be used to predict whether pancreatic cysts are benign or are precursors to invasive cancer.

4 Jun 2010

Today's OpEds: New Republic and National Review on health law; Conservative bloggers blast CBO numbers

The shouting war over health reform's effect on the budget got a little louder today when the director of the Office of Management and Budget, Peter Orszag, pushed back at conservative bloggers who are saying federal officials were disingenuous about the real costs of the law (Kate Steadman, 6/2).

4 Jun 2010

Abortion opponents focus on state law

"At least 11 states have passed laws this year regulating or restricting abortion, giving opponents of abortion what partisans on both sides of the issue say is an unusually high number of victories," The New York Times reports.

4 Jun 2010

Medical News

SERCA2a gene therapy proves effective in people with advanced heart failure: Researchers

Government health IT advisers examine privacy policies

PregLem reports positive Phase III data from PEARL I study of Esmya for uterine fibroids

Millipore shareholders approve acquisition of all outstanding shares of common stock by Merck KGaA

Intellect Neurosciences receives USPTO Notice of Allowance for IN-N01 monoclonal antibody patent

International development forum addresses U.S. foreign aid reform

Study: Delays in seeking health care appear to be common for Latino women

Nutrient found in maternal diet provide lasting cognitive, emotional benefits to people with Down syndrome: Study

European countries focus on drug price cuts

FDA approves Perrigo's ANDA for OTC Miconazole Nitrate Vaginal Cream and Suppository

Mass. insurers ask for double-digit rate hikes, again

New pricing of $19,500 set for Illumina's individual genome sequencing service

GHP selects MirixaPro web-based clinical platform to support delivery of MTM services

Health overhaul politics churn as regulators move forward

Drug makers push for more time to pay half-off discount on drugs

Anulex Technologies completes $20M Series E financing round

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Early detection and removal of pancreatic cysts may lower cancer risk: Researchers

Today's OpEds: New Republic and National Review on health law; Conservative bloggers blast CBO numbers

Abortion opponents focus on state law

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News